These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


414 related items for PubMed ID: 15329076

  • 1. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
    El-Khayat HA, Abd El-Basset FZ, Tomoum HY, Tohamy SM, Zaky AA, Mohamed MS, Hakky SM, El Barbary NS, Nassef NM.
    Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076
    [Abstract] [Full Text] [Related]

  • 2. Obesity and endocrine disorders in women taking valproate for epilepsy.
    Isojärvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV.
    Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
    [Abstract] [Full Text] [Related]

  • 3. Endocrine effects of valproate in adolescent girls with epilepsy.
    de Vries L, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H.
    Epilepsia; 2007 Mar; 48(3):470-7. PubMed ID: 17326798
    [Abstract] [Full Text] [Related]

  • 4. Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy.
    Mikkonen K, Tapanainen P, Pakarinen AJ, Päivänsalo M, Isojärvi JI, Vainionpää LK.
    Epilepsia; 2004 Jul; 45(7):769-76. PubMed ID: 15230700
    [Abstract] [Full Text] [Related]

  • 5. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X, Wang J, Dong W, Fang Q, Hu L, Liu C.
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [Abstract] [Full Text] [Related]

  • 6. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
    Mikkonen K, Knip M, Pakarinen AJ, Lanning P, Isojärvi JI, Vainionpää LK.
    Epilepsia; 2005 Jul; 46(7):1114-20. PubMed ID: 16026564
    [Abstract] [Full Text] [Related]

  • 7. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, Alge A, Windisch J, Lechleitner M, Bauer G.
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [Abstract] [Full Text] [Related]

  • 8. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV.
    N Engl J Med; 1993 Nov 04; 329(19):1383-8. PubMed ID: 8413434
    [Abstract] [Full Text] [Related]

  • 9. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy.
    Rättyä J, Vainionpää L, Knip M, Lanning P, Isojärvi JI.
    Pediatrics; 1999 Mar 04; 103(3):588-93. PubMed ID: 10049961
    [Abstract] [Full Text] [Related]

  • 10. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication.
    Löfgren E, Mikkonen K, Tolonen U, Pakarinen A, Koivunen R, Myllyla VV, Tapanainen JS, Isojärvi JI.
    Epilepsy Behav; 2007 Feb 04; 10(1):77-83. PubMed ID: 17098479
    [Abstract] [Full Text] [Related]

  • 11. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 Jun 04; 115(6):380-6. PubMed ID: 17701884
    [Abstract] [Full Text] [Related]

  • 12. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 04; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 13. Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy--a prospective randomized double-blind withdrawal study.
    Lossius MI, Taubøll E, Mowinckel P, Mørkrid L, Gjerstad L.
    Epilepsia; 2007 Oct 04; 48(10):1875-82. PubMed ID: 17555526
    [Abstract] [Full Text] [Related]

  • 14. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ, Kwan P, Shapiro D, Dominiczak M, Brodie MJ.
    Epilepsia; 2001 Aug 04; 42(8):1002-6. PubMed ID: 11554885
    [Abstract] [Full Text] [Related]

  • 15. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy.
    Vainionpää LK, Rättyä J, Knip M, Tapanainen JS, Pakarinen AJ, Lanning P, Tekay A, Myllylä VV, Isojärvi JI.
    Ann Neurol; 1999 Apr 04; 45(4):444-50. PubMed ID: 10211468
    [Abstract] [Full Text] [Related]

  • 16. Long-term reproductive endocrine health in young women with epilepsy during puberty.
    Mikkonen K, Vainionpää LK, Pakarinen AJ, Knip M, Järvelä IY, Tapanainen JS, Isojärvi JI.
    Neurology; 2004 Feb 10; 62(3):445-50. PubMed ID: 14872028
    [Abstract] [Full Text] [Related]

  • 17. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V, Pakarinen A, Knip M, Isojärvi J.
    Epilepsy Behav; 2006 May 10; 8(3):643-8. PubMed ID: 16600693
    [Abstract] [Full Text] [Related]

  • 18. Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment.
    Galimberti CA, Magri F, Copello F, Arbasino C, Cravello L, Casu M, Patrone V, Murialdo G.
    Epilepsia; 2005 Apr 10; 46(4):517-23. PubMed ID: 15816945
    [Abstract] [Full Text] [Related]

  • 19. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 10; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 20. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.
    McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ, Foster CM, Marshall JC.
    J Clin Endocrinol Metab; 2006 May 10; 91(5):1714-22. PubMed ID: 16492701
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.